Comparative in vitro activity of 1-oxa-beta-lactam (LY127935) and cefoperazone with other beta-lactam antibiotics against anaerobic bacteria

Author:

Borobio M V,Aznar J,Jimenez R,Garcia F,Perea E J

Abstract

The in vitro activity of 1-oxa-beta-lactam (LY127935), cefoperazone (T-1551), cefuroxime, cefsulodin, cefaclor, cefotaxime, and cefoxitin on 85 anaerobic clinical isolates (30 Bacteroides, 30 Clostridium, 25 Peptococcaceae) was simultaneously determined by the agar dilution test in two different media, Brucella Agar (Difco Laboratories) and Wilkins-Chalgren agar. In Wilkins-Chalgren agar, 90% of Bacteroides were inhibited by (micrograms per milliliter): LY127935, 0.5; T-1551, 64; cefoxitin or cefuroxime, 8; cefsulodin or cefotaxime, 32; and cefaclor, 128. All Clostridia were inhibited in Wilkins-Chalgren by (micrograms per milliliter): LY127935, 4; T-1551, 2; cefoxitin, 6; cefuroxime, 0.12; cefsulodin, 0.5; cefaclor, 1; and cefotaxime, 8. All Peptococccaceae were inhibited by T-1551, cefsulodin or cefotaxime at 4 microgram/ml and by cefoxitin or cefuroxime at 1 to 2 microgram/ml. With cefaclor at 8 microgram/ml, 92% of strains were inhibited, and LY127935 at 16 microgram/ml only inhibited 64% of strains. LY127935 was the most active of the antibiotics tested against Bacteroides, showing good activity against Clostridia and poor activity on Peptococcaceae, whereas T-1551 was more active against Peptococccaceae and had similar activity against Clostridia and poor activity on Bacteroides. There are no significant differences between minimal inhibitory concentrations obtained in Brucella Agar and those obtained in Wilkins-Chalgren.

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology

Reference13 articles.

1. In vitro activity of cefacolor against aerobic and anaerobic bacteria;Bach V. T.;Antimicrob. Agents Chemother.,1978

2. Comparative in vitro activity of new cephalosporins against anaerobic bacteria;Chow A. W.;Antimicrob. Agents Chemother.,1978

3. Cefotaxime (HR 756) a new cephalosporin with exceptional broad-spectrum activity in vitro;Hamilton-Miller J. M. T.;J. Antimicrob. Chemother.,1978

4. Holdeman L. V. and W. E. C. Moore (ed.). 1977. Anaerobe laboratory manual 4th ed. Virginia Polytechnic Institute and State University Blacksburg Va.

5. Cefuroxime, a new parenteral cephalosporin: collaborative in vitro susceptibility comparison with cephalotin against 5,887 clinical bacterial isolates;Jones R. N.;Antimicrob. Agents Chemother.,1977

Cited by 47 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. COMPARATIVE IN VITRO ACTIVITY OF FIRST, SECOND AND THIRD GENERATION CEPHALOSPORINS;Acta Pathologica Microbiologica Scandinavica Section B Microbiology;2009-08-19

2. THE IN VITRO ACTIVITY OF MOXALACTAM AGAINST 430 CLINICAL, BACTERIAL ISOLATES;Acta Pathologica Microbiologica Scandinavica Series B: Microbiology;2009-08-15

3. Effectiveness of cefotaxime alone and in combination with desacetylcefotaxime against Bacteroides fragilis;Diagnostic Microbiology and Infectious Disease;1989-01

4. Effect of pancreatitis on moxalactam excretion in pancreatic fluids of dogs and man;World Journal of Surgery;1988-06

5. Electron transfer mechanism for β-lactam antibiotic action via side-chain imine;Bioorganic Chemistry;1988-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3